Search for: "Janssen v. Janssen"
Results 241 - 260
of 385
Sorted by Relevance
|
Sort by Date
25 Jan 2021, 1:31 am
The Judge, citing previous Canadian case law, also dismissed the argument that the presence of an unexpected technical effect ("golden bonus" Janssen v Teva, 2015 FC 184) could rescue a claim that was obvious to try, given that "if a patentee obtains a workable formulation, the later discovery of one of its inherent characteristics does not add anything inventive to what had already been discovered" (para. [594], citing 2012 FC 410). [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
19 Aug 2021, 9:35 am
(Nasdaq, Rule 5801; Nasdaq, Rule 5830; Cory Janssen, Investopedia). [read post]
20 Dec 2023, 5:00 am
Janssen 2014). [read post]
28 Jul 2009, 3:54 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
11 Jan 2011, 11:07 pm
Supreme Court to take on patent settlement agreements: Louisiana Wholesale Drug Co et al v Bayer et al (FDA Law Blog) US: BIO joins 170 business, research institutions and organisations to urge caution in Microsoft v i4i case (PatentlyBIOtech) US: Galderma wins important victory in fight against Leo’s psoriasis patent covering vitamin D, corticosteroid composition for ‘dermal use’ (Reexamination Alert) US: Déjà vu! [read post]
28 Apr 2019, 7:45 am
In Janssen v Teva (2009) the Federal Circuit stated that mere plausibility does not suffice to meet this requirement, if it did then patents could be obtained for little more than “respectable guesses”. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape… [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]
22 Mar 2011, 5:08 am
Risperdal is different from other antipsychotic medicines and “doctors needed to know that,” he added.Jurors will begin deliberating the case tomorrow.The case is State of South Carolina v. [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
25 Jan 2011, 10:58 pm
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
24 Dec 2015, 8:20 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 777 S.E.2d 176 (S.C. 2015). [read post]
21 Jan 2015, 9:40 am
Janssen Pharmaceutica, Inc., 288 F. [read post]
20 Sep 2021, 3:31 pm
Janssen Pharmaceutica (appealing institution denials); Apple Inc. v. [read post]
21 Jul 2010, 9:49 pm
Forest (where the Federal Circuit held that blocking a generic drug company from selling a noninfringing product presents a justiciable controversy) than in Janssen v. [read post]
14 Aug 2009, 1:04 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
6 Aug 2009, 6:50 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
14 Aug 2009, 1:04 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
